VanEck Associates
EHC icon

VanEck Associates’s Encompass Health EHC Stock Holding History

VanEck Associates’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.18M Buy
84,517
+4,404
+5% +$452K 0.01% 650
2025
Q4 		$8.5M Buy
80,113
+2,102
+3% +$244K 0.01% 612
2025
Q3 		$9.91M Buy
78,011
+266
+0.3% +$31.7K 0.01% 551
2025
Q2 		$9.53M Buy
77,745
+71,189
+1,086% +$8.13M 0.01% 502
2025
Q1 		$664K Sell
6,556
-866
-12% -$84.6K ﹤0.01% 1105
2024
Q4 		$685K Sell
7,422
-338
-4% -$33.2K ﹤0.01% 1093
2024
Q3 		$742K Sell
7,760
-2,075
-21% -$186K ﹤0.01% 1037
2024
Q2 		$844K Sell
9,835
-174
-2% -$14.6K ﹤0.01% 1012
2024
Q1 		$827K Buy
+10,009
New +$733K ﹤0.01% 1003
2022
Q1 		– Sell
-19,148
Closed -$994K – 1382
2021
Q4 		$994K Buy
19,148
+2,988
+18% +$154K ﹤0.01% 845
2021
Q3 		$965K Buy
+16,160
New +$1.02M ﹤0.01% 812

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VanEck Associates's EHC Position: Q1 2026 in Review

VanEck Associates increased its Encompass Health (EHC) stake by 5.5% in Q1 2026, buying an estimated $452K and bringing the position to 84,517 shares worth $8.18M. The position accounts for 0.01% of the portfolio, ranked #650.

VanEck Associates first reported a position in EHC in Q3 2021 and has held it in 11 quarters since. The position peaked at $9.91M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • VanEck Associates held 84,517 shares of Encompass Health worth $8.18M as of Q1 2026.
  • VanEck Associates bought 4,404 Encompass Health shares in Q1 2026, an estimated $452K.
  • Encompass Health made up 0.01% of VanEck Associates's portfolio in Q1 2026, its #650 holding.
  • VanEck Associates first reported a position in Encompass Health in Q3 2021 and has held it in 11 quarters since.
  • VanEck Associates's Encompass Health position peaked at $9.91M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.